| 000 | 01674 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516142008.0 | ||
| 264 | 0 | _c20131230 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1432-198X | ||
| 024 | 7 |
_a10.1007/s00467-013-2450-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPabst, Werner Lukas | |
| 245 | 0 | 0 |
_aSuccessful long-term outcome after renal transplantation in a patient with atypical haemolytic uremic syndrome with combined membrane cofactor protein CD46 and complement factor I mutations. _h[electronic resource] |
| 260 |
_bPediatric nephrology (Berlin, Germany) _cJul 2013 |
||
| 300 |
_a1141-4 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAtypical Hemolytic Uremic Syndrome |
| 650 | 0 | 4 | _aBlood Component Transfusion |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aComplement Factor I _xgenetics |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 |
_aHemolytic-Uremic Syndrome _xgenetics |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Cofactor Protein _xgenetics |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aNeuhaus, Thomas J | |
| 700 | 1 | _aNef, Samuel | |
| 700 | 1 | _aBresin, Elena | |
| 700 | 1 | _aZingg-Schenk, Andrea | |
| 700 | 1 | _aSpartà , Giuseppina | |
| 773 | 0 |
_tPediatric nephrology (Berlin, Germany) _gvol. 28 _gno. 7 _gp. 1141-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00467-013-2450-7 _zAvailable from publisher's website |
| 999 |
_c22605582 _d22605582 |
||